Exploring New Vista for Alzheimer's Disease Drug Targets (Part II).
作者信息
Bolinger Andrew A, Zhou Jia
机构信息
Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555 USA.
Department of Pharmacology and Toxicology, University of Texas Medical Branch (UTMB), 301 University Blvd., Galveston, TX 77555 USA.
出版信息
Curr Top Med Chem. 2023;23(13):1211-1213. doi: 10.2174/156802662313230626121232.
Abstract
摘要
相似文献
1
Exploring New Vista for Alzheimer's Disease Drug Targets (Part II).探索阿尔茨海默病药物靶点的新前景（第二部分）。
Curr Top Med Chem. 2023;23(13):1211-1213. doi: 10.2174/156802662313230626121232.
2
Exploring New Vista for Alzheimer's Disease Drug Targets.探索阿尔茨海默病药物靶点的新前景。
Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.
3
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation.探索阿尔茨海默病及相关痴呆症与癌症及癌症治疗之间的联系：阿尔茨海默病协会与阿尔茨海默病药物发现基金会联合会议
Alzheimers Dement. 2017 Mar;13(3):267-273. doi: 10.1016/j.jalz.2016.11.002. Epub 2016 Dec 18.
4
Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study.将降压药物重新用于预防阿尔茨海默病：一项孟德尔随机化研究。
Int J Epidemiol. 2020 Aug 1;49(4):1132-1140. doi: 10.1093/ije/dyz155.
5
Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.多奈哌齐与维生素E治疗阿尔茨海默病：第2部分：轻度与中重度阿尔茨海默病
Clin Neuropharmacol. 2002 Jul-Aug;25(4):207-15. doi: 10.1097/00002826-200207000-00004.
6
Alzheimer's disease: clinical trials and drug development.阿尔茨海默病：临床试验与药物研发。
Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8.
7
Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer's Disease.阿尔茨海默病中的蛋白质-蛋白质相互作用和聚集抑制剂。
Curr Top Med Chem. 2019;19(7):501-533. doi: 10.2174/1568026619666190304153353.
8
Drug development status for Alzheimer's disease: present scenario.阿尔茨海默病药物研发状况：现状分析。
Neurol Sci. 2013 Jun;34(6):831-9. doi: 10.1007/s10072-013-1316-x. Epub 2013 Feb 8.
9
Amyloid forming proteases: therapeutic targets for Alzheimer's disease.淀粉样蛋白形成蛋白酶：阿尔茨海默病的治疗靶点
Curr Pharm Des. 2002;8(28):2521-31. doi: 10.2174/1381612023392658.
10
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.在加兰他敏治疗阿尔茨海默病的 VISTA 临床试验中，ADAS-cog 和临床上有意义的变化。
Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319.
本文引用的文献
1
Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review.用于早期诊断的阿尔茨海默病神经影像学：综述
Cureus. 2023 May 4;15(5):e38544. doi: 10.7759/cureus.38544. eCollection 2023 May.
2
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.阿尔茨海默病：草药药物的分子方面和治疗机会。
Ageing Res Rev. 2023 Jul;88:101960. doi: 10.1016/j.arr.2023.101960. Epub 2023 May 22.
3
Piperidine Nucleus as a Promising Scaffold for Alzheimer's Disease: Current Landscape and Future Perspective.哌啶核作为阿尔茨海默病有希望的支架：现状和未来展望。
Curr Top Med Chem. 2023;23(13):1221-1259. doi: 10.2174/1568026623666230406084315.
4
Plants of the Genus as a Potential Traditional Chinese Medicine for the Prevention and Treatment of Alzheimer's Disease.作为预防和治疗老年痴呆症的一种潜在的传统中药， 属植物。
Curr Top Med Chem. 2023;23(13):1214-1220. doi: 10.2174/1568026623666230330105251.
5
Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases.阿尔茨海默病痴呆管理的新方法以及 aducanumab 和 lecanemab 在其难治性病例治疗中的作用。
Dis Mon. 2023 May;69(5):101547. doi: 10.1016/j.disamonth.2023.101547. Epub 2023 Mar 15.
6
Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease.吖啶：用于开发阿尔茨海默病药物的支架。
Curr Top Med Chem. 2023;23(13):1260-1276. doi: 10.2174/1568026623666230203141543.
7
Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.阿尔茨海默病：系统视角为其发展提供了统一的解释。
J Alzheimers Dis. 2023;91(1):43-70. doi: 10.3233/JAD-220720.
8
Recent Advances in the Development of Nitrogen-containing Heterocyclic Anti-alzheimer's Agents.含氮杂环类抗老年痴呆药物的研究进展
Curr Top Med Chem. 2023;23(13):1277-1306. doi: 10.2174/1568026623666221019152502.
9
Neuroimmune contributions to Alzheimer's disease: a focus on human data.神经免疫对阿尔茨海默病的影响：关注人类数据。
Mol Psychiatry. 2022 Aug;27(8):3164-3181. doi: 10.1038/s41380-022-01637-0. Epub 2022 Jun 6.
10
Global estimates on the number of persons across the Alzheimer's disease continuum.全球范围内阿尔茨海默病患者人数的估计。
Alzheimers Dement. 2023 Feb;19(2):658-670. doi: 10.1002/alz.12694. Epub 2022 Jun 2.
Zotero 插件